{"log_id": 3709451870163062464, "direction": 0, "words_result_num": 46, "words_result": [{"probability": {"variance": 6.4e-05, "average": 0.997655, "min": 0.946001}, "location": {"width": 855, "top": 182, "height": 40, "left": 184}, "words": "与其他的阿片类药物一样,颅脑损伤的患者使用布托啡诺可能会出现二氧化碳潴留和继发性的脑脊髓"}, {"probability": {"variance": 0.000327, "average": 0.995597, "min": 0.875942}, "location": {"width": 896, "top": 216, "height": 39, "left": 143}, "words": "液压升高、药物诱导的缩瞳和精神状态改变,从而影响了对颅脑损伤患者临床过程的判断。因此在这些患"}, {"probability": {"variance": 5e-06, "average": 0.998559, "min": 0.990344}, "location": {"width": 495, "top": 254, "height": 35, "left": 143}, "words": "者中,只有在使用益处超过潜在风险时才可使用布托啡诺"}, {"probability": {"variance": 3e-06, "average": 0.99845, "min": 0.995406}, "location": {"width": 183, "top": 294, "height": 27, "left": 144}, "words": "呼吸功能紊乱或抑制"}, {"probability": {"variance": 8.6e-05, "average": 0.996126, "min": 0.942726}, "location": {"width": 854, "top": 316, "height": 38, "left": 184}, "words": "布托啡诺可能会引起呼吸抑制,尤其是同时服用其他CNS激动剂的患者,或患有CNS疾病或呼吸障"}, {"probability": {"variance": 0, "average": 0.999308, "min": 0.998311}, "location": {"width": 84, "top": 360, "height": 25, "left": 144}, "words": "碍的患者"}, {"probability": {"variance": 0, "average": 0.999324, "min": 0.998381}, "location": {"width": 85, "top": 393, "height": 26, "left": 144}, "words": "肝肾疾病"}, {"probability": {"variance": 0.000594, "average": 0.992612, "min": 0.868586}, "location": {"width": 847, "top": 416, "height": 35, "left": 184}, "words": "肝或肾功能不全的患者,酒石酸布托啡诺注射液的初始给药剂量一般为成人推荐剂量的一半(0.5mg"}, {"probability": {"variance": 0.00555, "average": 0.978148, "min": 0.526345}, "location": {"width": 894, "top": 445, "height": 40, "left": 147}, "words": "IV和1.0mgIM)。应该根据患者的反应确定重复给药的间隔时间,而不是固定的间隔,但一般时间间隔不"}, {"probability": {"variance": 0, "average": 0.999351, "min": 0.998648}, "location": {"width": 106, "top": 491, "height": 23, "left": 147}, "words": "少于6小时"}, {"probability": {"variance": 0, "average": 0.999807, "min": 0.999545}, "location": {"width": 102, "top": 521, "height": 27, "left": 148}, "words": "心血管影响"}, {"probability": {"variance": 4.5e-05, "average": 0.997783, "min": 0.962458}, "location": {"width": 856, "top": 544, "height": 38, "left": 186}, "words": "由于布托啡诺可能会增加心脏的工作,尤其是肺部循环,急性心肌梗塞、心室功能障碍或冠状动脉供"}, {"probability": {"variance": 8e-06, "average": 0.998434, "min": 0.987737}, "location": {"width": 496, "top": 581, "height": 33, "left": 146}, "words": "血不足的患者只有益处明显大于风险时才可考虑使用本品"}, {"probability": {"variance": 8e-06, "average": 0.998052, "min": 0.987477}, "location": {"width": 856, "top": 608, "height": 38, "left": 186}, "words": "布托啡诺治疗中罕有严重高血压出现。但是一旦出现此类情况,需停用布托啡诺,并用抗高血压药治"}, {"probability": {"variance": 1.2e-05, "average": 0.998079, "min": 0.988005}, "location": {"width": 416, "top": 646, "height": 31, "left": 148}, "words": "疗。非阿片依赖的患者使用纳洛酮治疗是有效的"}, {"probability": {"variance": 0.000344, "average": 0.988425, "min": 0.947124}, "location": {"width": 161, "top": 682, "height": 25, "left": 150}, "words": "门诊患者中的使用"}, {"probability": {"variance": 0.025605, "average": 0.605906, "min": 0.445889}, "location": {"width": 174, "top": 637, "height": 73, "left": 946}, "words": "有公"}, {"probability": {"variance": 1.1e-05, "average": 0.998163, "min": 0.988025}, "location": {"width": 845, "top": 703, "height": 33, "left": 217}, "words": "阿片类镇痛药物,包括布托啡诺,可损伤精神和身体能力,比如从事驾驶汽车或操作机械等潜在"}, {"probability": {"variance": 0, "average": 0.930022, "min": 0.930022}, "location": {"width": 49, "top": 703, "height": 42, "left": 1084}, "words": "产"}, {"probability": {"variance": 4.2e-05, "average": 0.995865, "min": 0.968982}, "location": {"width": 891, "top": 733, "height": 38, "left": 149}, "words": "危险工作时。通常在给药后一小时内出现困倦或头晕。给药后此类作用的持续时间不同。因此患者服用布"}, {"probability": {"variance": 3e-06, "average": 0.998686, "min": 0.992439}, "location": {"width": 591, "top": 769, "height": 32, "left": 150}, "words": "托啡诺后一小时内不宜驾驶或操作危险的机器,直到药物的作用消失"}, {"probability": {"variance": 0.000108, "average": 0.994611, "min": 0.955637}, "location": {"width": 859, "top": 796, "height": 37, "left": 187}, "words": "2.服药期间不宜饮酒。影响中枢神经系统的药物(如酒精、巴比妥类、镇定剂和抗组胺药)与布托啡诺"}, {"probability": {"variance": 8e-06, "average": 0.99804, "min": 0.990204}, "location": {"width": 653, "top": 829, "height": 37, "left": 150}, "words": "联用可能会导致中枢神经系统抑制作用增加,如困倦、头晕或心理功能受损"}, {"probability": {"variance": 0.00015, "average": 0.996014, "min": 0.932266}, "location": {"width": 559, "top": 862, "height": 33, "left": 188}, "words": "3.布托啡诺是一类被滥用的药物之一,因此应该进行相应的处理"}, {"probability": {"variance": 1e-06, "average": 0.999065, "min": 0.997293}, "location": {"width": 164, "top": 900, "height": 27, "left": 150}, "words": "药物滥用和依赖性"}, {"probability": {"variance": 0.005538, "average": 0.982044, "min": 0.569857}, "location": {"width": 648, "top": 924, "height": 33, "left": 191}, "words": "药物滥用—酒石酸布托啡诺通过各种途径给药都可能导致药物滥用的发生"}, {"probability": {"variance": 0.009052, "average": 0.983324, "min": 0.366992}, "location": {"width": 857, "top": 953, "height": 36, "left": 190}, "words": "身体依赖性、耐受性和戒断长期、连续使用酒石酸布托啡诺可能导致身体依赖性或耐受性(对所"}, {"probability": {"variance": 3e-06, "average": 0.998947, "min": 0.992946}, "location": {"width": 654, "top": 986, "height": 35, "left": 150}, "words": "给剂量的反应减少),产生身体依赖性的患者突然停用可能会引起戒断症状"}, {"probability": {"variance": 0.00119, "average": 0.992601, "min": 0.770282}, "location": {"width": 857, "top": 1016, "height": 36, "left": 191}, "words": "注意—选择合适的患者、给予合适剂量、对处方的限制、合适的使用指导和频繁的监测对于降低药"}, {"probability": {"variance": 5e-06, "average": 0.998465, "min": 0.990227}, "location": {"width": 338, "top": 1052, "height": 34, "left": 153}, "words": "物滥用和身体依赖性的风险是很重要的"}, {"probability": {"variance": 1.7e-05, "average": 0.998083, "min": 0.984498}, "location": {"width": 228, "top": 1093, "height": 27, "left": 160}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.000138, "average": 0.986666, "min": 0.974898}, "location": {"width": 43, "top": 1129, "height": 23, "left": 153}, "words": "妊娠"}, {"probability": {"variance": 3e-05, "average": 0.997583, "min": 0.968586}, "location": {"width": 857, "top": 1148, "height": 37, "left": 193}, "words": "妊娠类型C:器官发生期小鼠、大鼠和家兔生殖毒性研究显示本品无任何致畸性。然而,怀孕大鼠皮"}, {"probability": {"variance": 0.006161, "average": 0.969719, "min": 0.519658}, "location": {"width": 891, "top": 1180, "height": 38, "left": 157}, "words": "下给予布托啡诺1mg/kg(5.9mg/m2)后死产率较对照组略高。家兔口服布托啡诺30mgkg360mg/m2)和"}, {"probability": {"variance": 0.000528, "average": 0.989291, "min": 0.889625}, "location": {"width": 427, "top": 1216, "height": 36, "left": 187}, "words": "gkg(720mg/m2)后的植入后损失的发生率相对增加"}, {"probability": {"variance": 1.3e-05, "average": 0.998141, "min": 0.975657}, "location": {"width": 853, "top": 1242, "height": 38, "left": 197}, "words": "布托啡诺没有在孕37周内的妇女中进行足够的和良好对照的研究,所以最好不要用药,只有潜在利"}, {"probability": {"variance": 1e-06, "average": 0.999101, "min": 0.994226}, "location": {"width": 514, "top": 1279, "height": 33, "left": 156}, "words": "益大于对胎儿的潜在风险时,妊娠期妇女才可使用布托啡诺"}, {"probability": {"variance": 1e-06, "average": 0.998996, "min": 0.998041}, "location": {"width": 44, "top": 1318, "height": 26, "left": 156}, "words": "分娩"}, {"probability": {"variance": 0.001512, "average": 0.991845, "min": 0.739533}, "location": {"width": 856, "top": 1338, "height": 37, "left": 195}, "words": "分娩时给予布托啡诺注射液后出现婴儿呼吸抑制或呼吸暂停的事件罕有发生。呼吸抑制或呼吸暂停的"}, {"probability": {"variance": 3.4e-05, "average": 0.99727, "min": 0.966827}, "location": {"width": 786, "top": 1370, "height": 39, "left": 156}, "words": "报道一般发生在分娩2小时内给药、使用多剂量、使用其他镇痛或镇静药物、或早产使用时"}, {"probability": {"variance": 2.1e-05, "average": 0.997497, "min": 0.979583}, "location": {"width": 854, "top": 1401, "height": 39, "left": 198}, "words": "在119名患者的研究中,分娩期间静脉给予1mg布托啡诺注射液后胎儿出现暂时性正弦胎儿心率模"}, {"probability": {"variance": 0.034082, "average": 0.906946, "min": 0.495134}, "location": {"width": 75, "top": 1448, "height": 23, "left": 159}, "words": "式(1090"}, {"probability": {"variance": 7e-06, "average": 0.998878, "min": 0.985441}, "location": {"width": 652, "top": 1437, "height": 34, "left": 289}, "words": "但是新生儿没有不良反应。在存在异常的胎儿心率模式时,使用本品应谨慎"}, {"probability": {"variance": 1e-06, "average": 0.999275, "min": 0.998226}, "location": {"width": 52, "top": 1480, "height": 25, "left": 158}, "words": "哺乳:"}, {"probability": {"variance": 0.00028, "average": 0.993937, "min": 0.908423}, "location": {"width": 856, "top": 1501, "height": 36, "left": 198}, "words": "哺乳期妇女静脉给予布托啡诺注射液后,在乳汁中可检测到布托啡诺。婴儿的摄入量很可能无临床意"}, {"probability": {"variance": 0.006182, "average": 0.981176, "min": 0.514148}, "location": {"width": 678, "top": 1534, "height": 35, "left": 160}, "words": "义(母亲每天四次肌注2mg后乳汁分泌量为4ug/L)。哺乳期妇女用药应权衡利弊"}], "language": 3}